Company page
Havn Life Sciences Inc
Havn Life Sciences Inc, traded under the ticker HAVN, operates in the Canadian market with a market capitalization of approximately $544,183. The company focuses on the development and commercialization of psychedelic compounds for various therapeutic applications. Havn Life aims to advance the understanding and accessibility of these substances in the healthcare sector.
- Ticker
- HAVN:CSE
- Asset type
- Stock
- Market cap
- $544,183
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- CSE
- Currency
- CAD